statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Bitcoin

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Invesco QQQ Trust Series 1

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Virpax Regains Compliance with Nasdaq Minimum Bid Price

Virpax Pharmaceuticals, Inc. (Virpax or the Company) (NASDAQ: VRPX), a company specializing in developing non-addictive products for pain management, post-traumatic stress disorder, central nervous...

3 Penny Stocks to Watch Now, 7/23/24

Personalis Inc., SunPower, and Virpax Pharmaceuticals are the 3 Penny Stocks to watch on July 23, based on TipRanks' Penny Stock Screener tool...

Crude Oil Gains Over 1%; Virpax Pharmaceuticals Shares Spike Higher

Pain Management-Focused Penny Stock Virpax Pharmaceuticals Surges Over 100% On Wednesday-Here's Why?

Virpax Pharmaceuticals reports positive results from a Swine Model pilot study of Probudur. Shares surged 169.8% on strong volume. Probudur showed a long-term, slow-release profile with no adverse...

Virpax Announces Positive Results of Swine Model Pilot Study for Probudur

Virpax Pharmaceuticals Secures $2.5 Million Loan Financing and an Agreement with an Institutional Investor to Negotiate Additional Funding

Virpax Pharmaceuticals to Present at 2024 BIO International Convention

Virpax Announces Pricing of $2.25 Million Public Offering

Virpax Pharmaceuticals Reports 2024 First Quarter Results and Recent Developments

Virpax Announces Results of Maximum Tolerated Dose Study for Probudur

Virpax Pharmaceuticals, Inc. is a preclinical stage biopharmaceutical company, which engages in the development of branded, non-addictive pain management products. Its products include metered-dose spray, liposomal gel encapsulates, and intranasal spray. The company was founded by Anthony P. Mack and Jeffrey A. Gudin in 2016 and and is headquartered in Berwyn, PA.

Virpax Pharmaceuticals Inc

Volume	590,828.00
52-Wk High	$9.50
52-Wk Low	$0.4603

VRPX Virpax Pharmaceuticals Inc

About

Feed

News

Fundamentals